Corrigendum

Corrigendum Corrigendum (728) Total Article Views Authors: Millholland JM, Li S, Fernandez CA, Shuber AP Published Date September 2012 Volume 2012:4 Pages 47 - 48 DOI: http://dx.doi.org/10.2147/RRU.S36425 Received: 27 July 2012 Accepted: 27 July 2012 Published: 12 September 2012 Millholland JM, Li S, Fernandez CA, Shuber AP. Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing. Research and Reports in Urology; 2012;4:33–40. "Small-molecule FGFR3" on pages 37 and 38 in the published paper is incorrect: The correct term should read: "Single-molecule FGFR3." The abbreviation keys for Table 4 and Table 5 on page 38 incorrectly indicate smFGFR3 is an abbreviation of small-molecule FGFR3. The correct meaning of smFGFR3 is single-molecule FGFR3 Read the original paper Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Other articles by Dr Cecilia Fernandez A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing Molecular grading of tumors of the upper urothelial tract using FGFR3 mutation status identifies patients with favorable prognosis Noninvasive multianalyte diagnostic assay for monitoring bladder cancer recurrence Readers of this article also read: Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome Neurotransmitter testing of the urine: a comprehensive analysis Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine Correcting magnesium deficiencies may prolong life Photoselective vaporization of the prostate with the 120W lithium triborate laser for the treatment of acute urinary retention Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing Noninvasive multianalyte diagnostic assay for monitoring bladder cancer recurrence Dexmedetomidine sedation in painful posterior segment surgery Current and emerging treatment options for Peyronie's disease